Cargando…
Focal segmental glomerulosclerosis associated with the use of the IL-23 inhibitor guselkumab
We report a case of a 38-year-old man who developed a nephrotic syndrome shortly after the start of guselkumab for the treatment of plaque psoriasis. Renal biopsy showed focal segmental glomerulosclerosis (FSGS). The clinical course of our case is highly suspect for drug-induced FSGS since the nephr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539213/ https://www.ncbi.nlm.nih.gov/pubmed/37779841 http://dx.doi.org/10.1093/ckj/sfad161 |